Cargando…

Converged DNA Damage Response Renders Human Hepatocellular Carcinoma Sensitive to CDK7 Inhibition

SIMPLE SUMMARY: Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer. HCC has a dismal five-year mortality estimate of >95%, ranking as the fourth leading cause of cancer-related mortality worldwide. Despite the recent progression in the treatment of HCC with multikinase...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xie, Guiqin, Zhu, Ailin, Gu, Xinbin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996977/ https://www.ncbi.nlm.nih.gov/pubmed/35406486 http://dx.doi.org/10.3390/cancers14071714

Ejemplares similares

Mutations that prevent methylation of cohesin render sensitivity to DNA damage in S. pombe
por: Sanyal, Swastika, et al.
Publicado: (2018)

Herbal Compound “Songyou Yin” Renders Hepatocellular Carcinoma Sensitive to Oxaliplatin through Inhibition of Stemness
por: Jia, Qing-An, et al.
Publicado: (2012)

SPDR-4 SLFN11 RENDERS MEDULLOBLASTOMA SENSITIVE TO DNA DAMAGE CHEMOTHERAPIES
por: Nakata, Satoshi, et al.
Publicado: (2022)

Dependency of the Spindle Assembly Checkpoint on Cdk1 Renders the Anaphase Transition Irreversible
por: Rattani, Ahmed, et al.
Publicado: (2014)

Antitumor Efficacy of EGFR-Targeted Recombinant Immunotoxin in Human Head and Neck Squamous Cell Carcinoma
por: Xie, Guiqin, et al.
Publicado: (2022)

CDK9 Inhibition Induces a Metabolic Switch that Renders Prostate Cancer Cells Dependent on Fatty Acid Oxidation
por: Itkonen, Harri M., et al.
Publicado: (2019)

CDK Inhibition Reverses Acquired 5-Fluorouracil Resistance in Hepatocellular Carcinoma Cells
por: Pu, Yiyi, et al.
Publicado: (2022)

Cdk5 links with DNA damage response and cancer
por: Liu, Wan, et al.
Publicado: (2017)

Selective human inhibitors of ATR and ATM render Leishmania major promastigotes sensitive to oxidative damage
por: da Silva, Raíssa Bernardes, et al.
Publicado: (2018)

PBRM1 mutations might render a subtype of biliary tract cancers sensitive to drugs targeting the DNA damage repair system
por: Zimmer, Kai, et al.
Publicado: (2023)

ATRT-20. CDK7 INHIBITION IN AT/RT
por: Morin, Andrew, et al.
Publicado: (2020)

ATRT-24. CDK7 Inhibition in AT/RT
por: Morin, Andrew, et al.
Publicado: (2022)

Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion
por: Zarei, Mahsa, et al.
Publicado: (2019)

Treatment of Teeth Rendered Sensitive by Mechanical Abrasion
Publicado: (1868)

A dual role of Cdk2 in DNA damage response
por: Satyanarayana, Ande, et al.
Publicado: (2009)

GPU Pro 7: advanced rendering techniques
por: Engel, Wolfgang
Publicado: (2016)

The DNA damage and the DNA replication checkpoints converge at the MBF transcription factor
por: Ivanova, Tsvetomira, et al.
Publicado: (2013)

miR‐206 inhibits the growth of hepatocellular carcinoma cells via targeting CDK9
por: Pang, Chi, et al.
Publicado: (2017)

Inhibition of c-Abl Kinase Activity Renders Cancer Cells Highly Sensitive to Mitoxantrone
por: Alpay, Kemal, et al.
Publicado: (2014)

Tankyrase inhibition sensitizes cells to CDK4 blockade
por: Foronda, Miguel, et al.
Publicado: (2019)

Involvement of DNA Damage Response Pathways in Hepatocellular Carcinoma
por: Yang, Sheau-Fang, et al.
Publicado: (2014)

Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13
por: Zeng, Mei, et al.
Publicado: (2018)

MON-LB80 Human Thyroid Cancer Cells Are Highly Sensitive to CDK7 and 9 Inhibition
por: Rajan, Neel, et al.
Publicado: (2020)

Slow mitochondrial repair of 5′-AMP renders mtDNA susceptible to damage in APTX deficient cells
por: Akbari, Mansour, et al.
Publicado: (2015)

Chemotherapy induced DNA damage response: Convergence of drugs and pathways
por: Woods, Derek, et al.
Publicado: (2013)

Recombinant immunotoxin induces tumor intrinsic STING signaling against head and neck squamous cell carcinoma
por: Xie, Guiqin, et al.
Publicado: (2023)

PRCC reduces the sensitivity of cancer cells to DNA damage by inhibiting JNK and ATM/ATR pathways and results in a poor prognosis in hepatocellular carcinoma
por: Liu, Chunying, et al.
Publicado: (2021)

Dihydrotanshinone I inhibits hepatocellular carcinoma cells proliferation through DNA damage and EGFR pathway
por: Wang, Linjun, et al.
Publicado: (2023)

CDK4/6 Inhibition Induces Senescence and Enhances Radiation Response by Disabling DNA Damage Repair in Oral Cavity Squamous Cell Carcinoma
por: Shrivastava, Nitisha, et al.
Publicado: (2023)

Overall Cdk activity modulates the DNA damage response in mammalian cells
por: Cerqueira, Antonio, et al.
Publicado: (2009)

Palbociclib induces activation of AMPK and inhibits hepatocellular carcinoma in a CDK4/6‐independent manner
por: Hsieh, Feng‐Shu, et al.
Publicado: (2017)

Splicing factor deficits render hematopoietic stem and progenitor cells sensitive to STAT3 inhibition
por: Potts, Kathryn S., et al.
Publicado: (2022)

Autophagy inhibition sensitizes hepatocellular carcinoma to the multikinase inhibitor linifanib
por: Pan, Hongming, et al.
Publicado: (2014)

CDK4/6 Inhibitor Palbociclib Amplifies the Radiosensitivity to Nasopharyngeal Carcinoma Cells via Mediating Apoptosis and Suppressing DNA Damage Repair
por: Xie, Xianhe, et al.
Publicado: (2019)

DNA Replication Vulnerabilities Render Ovarian Cancer Cells Sensitive to Poly(ADP-Ribose) Glycohydrolase Inhibitors
por: Pillay, Nisha, et al.
Publicado: (2019)

Frequent Amplification of CENPF, GMNN and CDK13 Genes in Hepatocellular Carcinomas
por: Kim, Hye-Eun, et al.
Publicado: (2012)

TIGAR regulates DNA damage and repair through pentosephosphate pathway and Cdk5-ATM pathway
por: Yu, Hong-Pei, et al.
Publicado: (2015)

Rendering for beginners: image synthesis using RenderMan
por: Raghavachary, Saty
Publicado: (2004)

Residual Cdk1/2 activity after DNA damage promotes senescence
por: Müllers, Erik, et al.
Publicado: (2017)

ARNTL hypermethylation promotes tumorigenesis and inhibits cisplatin sensitivity by activating CDK5 transcription in nasopharyngeal carcinoma
por: Peng, Hao, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_g53fchmbjpcv17v9gla1dmib97